Shallcross Steven A has bought 26,000 shares of Theriva Biologics, Inc. [SYN] at $0.63 a share.
Theriva Biologics, Inc. [SYN] disclosed in an SEC Form 4 submission Tuesday, June 6, 2023 that the deal increased Shallcross Steven A's holding in the company to 236,000.
Theriva Biologics, Inc. [SYN] is a Pharmaceutical Preparations company based in Nevada.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.